The analysis of the chemical drugs among structural isomer

被引:10
作者
Doi, Kayo
Miyazawa, Maki
Fujii, Hisashi
Kojima, Takashi
机构
[1] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa 2530087, Japan
[2] Kanagawa Ind Technol Ctr, Ebina City 2430435, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2006年 / 126卷 / 09期
关键词
abuse drug; structural isomerism; 5-methoxy-N; N-di-iso-propyl-tryptamine; N-di-n-propyl-tryptamine; chemical drug;
D O I
10.1248/yakushi.126.815
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drugs that have a pharmacological effect similar to legal drugs such as narcotics and stimulants are available in the market and widely used. 5-methoxy-N,N-di-iso-propyl-tryptamine (5MeO-DIPT) and a-methyl-tryptamine (AMT) were categorized as narcotics and were specified as legal drugs in April 2005, and also 2,5-dimethoxy-4-n-propylthiophenethylamine (4C-T-7) and N-methyl-alpha-ethy-3,4-methylenedioxy-phenethylamine (MBDB) were categorized as narcotics and were specified as legal drugs in April 2006, in Japan. We are analyzing these chemical drugs by investigating the market research. It is recognized that during the analysis of chemical drugs, drugs that resemble a structural isomer of a target substance, such as 5MeO-DIPT and 5-methoxy-N,N-di-n-propyl-tryptamine (5MeO-DPT) or 4C-T-7 and 2,5-dimethoxy-4-iso-propylthiophenethylamine (4C-T-4), should be distinguished. The results of TLC, IR, GC-MS and HPLC analyses were compared. 5MeO-DIPT and 5MeO-DPT could be distinguished by TLC and HPLC analyses, but not by IR and GC-MS analysis. The drugs 4-hydroxy-N-methyl-N-iso-propyl-tryptamine (4HO-MIPT) and 4-hydroxy-N,N-di-ethyl-tryptamine (4HO-DET) or could not be distinguished. Moreover, the isomers of 4-hydroxy-N-methyl-N-n-propyl-tryptamine (4HO-MPT) was not found to be present. Thus, we have demonstrated that the chemical drug could be distinguished from each other, and we have also shown that NMR data is essential for the analysis.
引用
收藏
页码:815 / 823
页数:9
相关论文
共 7 条
[1]  
KOJIMA T, 2000, JPN J TOXICOL, V13, P85
[2]  
KOJIMA T, 2004, JPN J TOXICOL, V17, P71
[3]  
KUROKI Y, 2004, JPN J TOXICOL, V17, P241
[4]  
SHULGIN A, 2000, PIHKAL CHEM LOVE STO, P451
[5]  
SHULGIN A, 1997, TIHKAL CONTITUATION, P387
[6]  
TABE M, 2004, JPN J TOXICOL, V17, P251
[7]   Potential usefulness of bovine lactoferrin for adjunctive immunotherapy for mucosal Candida infections [J].
Yamaguchi, H ;
Abe, S ;
Takakura, N .
BIOMETALS, 2004, 17 (03) :245-248